Lionel G.
- Country
- France
- Department
- Oncology
Research Overview
- Phase II Open-Label Evaluation of Sacituzumab Govitecan in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma
- Evaluation of Pembrolizumab and Axitinib Combination Versus Sunitinib Monotherapy in First-line Treatment of Metastatic Renal Cell Carcinoma
- Phase II Evaluation of Atezolizumab Maintenance Post-Chemo-Radiotherapy in Muscle-Invasive Bladder Cancer Patients Ineligible for Radical Cystectomy
Data & Insights
Has run more than one trial at 84 of 234 partner sites.
Specializations
Renal Cancer Research
Primary focus on developing treatments for metastatic renal cell carcinoma, including studies of both clear cell and non-clear cell variants. Particular expertise in evaluating novel therapeutic combinations with immune checkpoint inhibitors and targeted therapies.
- First-line treatment strategies
- Brain metastasis management
- Combination immunotherapy approaches
Head and Neck Cancer
Extensive research in squamous cell carcinoma of the head and neck, investigating innovative treatment approaches including immunotherapy combinations and targeted therapies. Focus on both locally advanced and metastatic disease settings.
- Recurrent/metastatic disease
- Novel immunotherapy combinations
- Treatment-resistant cases
Urological Cancers
Specialized research in urothelial carcinoma and muscle-invasive bladder cancer. Investigation of novel therapeutic approaches including antibody-drug conjugates and immunotherapy combinations.
- Advanced bladder cancer
- Neoadjuvant treatments
- Maintenance therapy strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.